Physicians generally use a blood test, referred to as the PSA test, to screen men with no symptoms for prostate cancer.  Physicians generally agree that high PSA levels require a need to let the patient know he may have cancer and to either refer the patient to a specialist or follow up with diagnostic testing to rule out prostate cancer.  Yet, delayed diagnosis of prostate cancer cases occur all too frequently. 

Consider the following reported cases.  In the first reported case, a doctor help off for two years after consecutive high PSA test results prior to telling the man that the patient might have cancer.  By the time the man was diagnosed he already had advanced prostate cancer.  The law firm that represented this man reported they were able to settle the lawsuit for $600,000 on the man’s behalf.  In the second reported case, a doctor waited 16 months, with three consecutive high PSA readings, prior to letting the patient know, a sixty-four year old man.  Prior to that the doctor had actually told the man that the results were normal for a man his age.  The result: the cancer had already reached the man’s seminal vesicles. The law firm that handled this claim was able to report a settlement of $1,500,000 on the man’s behalf. 

As these two cases illustrate, if a doctor does not follow up on an abnormal result from a cancer screening test and the patient’s cancer spreads during the delay caused by the physician, a cancer lawyer can help you figure out whether that doctor is liable for malpractice.  In the worst case situation, a wrongful death attorney can help the patient’s family determine whether they may have a claim for wrongful death.  The above should not be considered medical or legal advice.  You should always consult with a doctor before taking medical advice or making a medical decision.  And always consult with an attorney concerning any potential legal matter.

People suffering from manic depression go through continuous bouts of mania and depression that affects them their entire life.

The cause of bipolar 1 disorder disease has been the focus of many studies but scientist may finally be getting closer to the crux of the problem.

Can gene study lead researchers to discover the cause of manic depression? Some researchers seem to think so as a recent study points to two genes that seem as though they may play a central part in determining a person’s risk for developing manic depression.

If true, the importance of the discovery may lead to a whole host of new and better treatments to combat the disorder.

The 2 genes that are causing all of the signs and symptoms of manic depression are the ANK3 gene and the CACNA1C gene. The ANK3 gene is located on chromosome 10 at position q21. The CACNA1C gene is important in the production of the calcium channels which can be found in many of the body’s cells and are especially critical to the functioning of the heart and brain cells.

Moreover, it’s known that the proteins created by these genes indirectly influences the activity in the nerve cells of the brain by controlling the flow of sodium and calcium in the brain.

And now, after having discovered the specific genes responsible for bipolar disorder, they can begin to work on treatments that target the gene directly.

For further information on bipolar disorder test and other bipolar issues, please visit Julie’s website.

Disclaimer: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.

Best Registry Repair